ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
프로테우스 증후군 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 연평균 5.0%의 성장률(CAGR)로 16억 6,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 맞춤형 의료에 대한 관심 증가, 바이오마커 활용 확대, 원격의료 도입 확대, 희귀 질환에 대한 인식 증가, 프로테우스 증후군의 보급률 증가에 기인할 것으로 보입니다. 예측 기간 동안 예상되는 주요 동향으로는 기술 발전, 유전자 치료의 혁신, AI 기반 진단, 빅데이터 분석의 통합, 맞춤형 의약품 개발 등이 있습니다.
유전자 돌연변이의 빈도 증가는 향후 몇 년 동안 프로테우스 증후군 시장의 성장을 촉진할 것으로 예상됩니다. 유전자 돌연변이는 유전 정보를 변화시키는 DNA 염기서열의 영구적인 변화로 다양한 질병이나 특정 형질을 유발할 수 있습니다. 유전자 돌연변이 증가의 주요 원인은 방사선, 오염물질, 화학제품과 같은 돌연변이 유발 물질에 대한 환경적 노출이며, 이들은 DNA 손상과 유전자 변화를 유발합니다. 프로테우스 증후군은 AKT1 유전자의 체세포 돌연변이가 어떻게 비정상적인 세포 증식을 유발하는지를 입증함으로써 유전자 돌연변이에 대한 이해에 기여하고, 모자이크와 질병 진행에 대한 귀중한 인사이트를 제공하고 있습니다. 예를 들어, 2022년 3월 영국 보건부는 영국 내에서 763개의 XE 염기서열과 637건의 사례를 보고했으며, XE 돌연변이는 영국 전역에 퍼져 있으며, 사례 수는 증가하고 있습니다. 이처럼 유전자 돌연변이 발생률의 증가는 프로테우스 증후군 시장 확대에 박차를 가하고 있습니다.
연구 자금의 증가는 프로테우스 증후군 시장의 성장을 더욱 가속화할 것으로 예상됩니다. 연구 자금은 과학적 발견, 혁신 및 기술 발전을 촉진하기 위한 정부, 조직 및 기관의 재정적 지원을 의미합니다. 이러한 자금 지원의 증가는 주로 프로테우스 증후군의 유전적 원인을 더 깊이 이해하고, 진단 방법을 개선하고, 표적 치료법을 개발해야 할 필요성에 의해 이루어지고 있습니다. 이 질환은 첨단 유전학 및 치료학 연구의 중요성을 강조하기 위해 많은 연구 자금을 모으고 있으며, 의료 기관, 정부 기관 및 희귀 질환 단체의 투자를 유도하고 있습니다. 예를 들어, 2024년 8월 영국의 생명과학 및 바이오테크놀러지 업계 단체인 바이오산업협회(BioIndustry Association)는 영국의 생명과학 및 바이오테크놀러지 부문이 올해 첫 2분기에 25억 5,000만 달러의 투자를 확보했다고 발표했습니다. 25억 5천만 달러의 투자를 확보하여 2023년에 조달한 23억 2,000만 달러를 넘어섰다고 보고했습니다. 이처럼 연구 자금의 증가는 프로테우스 증후군 시장 개척을 촉진하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계 프로테우스 증후군 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 프로테우스 증후군 시장 : 성장률 분석
세계의 프로테우스 증후군 시장 실적 : 규모와 성장, 2019-2024
세계의 프로테우스 증후군 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계 프로테우스 증후군 전체 시장(TAM)
제6장 시장 세분화
세계의 프로테우스 증후군 시장 : 제품 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
태블릿
캡슐
주사제
기타 제품 유형
세계의 프로테우스 증후군 시장 : 투여 경로별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
경구
비경구
기타 투여 경로
세계의 프로테우스 증후군 시장 : 유통 채널별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
온라인
오프라인
세계의 프로테우스 증후군 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원 약국
소매 약국
전문 클리닉
세계의 프로테우스 증후군 시장 정제 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
즉방정
서방정
발포정
세계의 프로테우스 증후군 시장 캡슐 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
하드 젤라틴 캡슐
소프트 젤라틴 캡슐
지연 방출 캡슐
세계의 프로테우스 증후군 시장, 주사제 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
정맥내(IV) 주사제
근육내(IM) 주사제
피하주사 제
세계의 프로테우스 증후군 시장, 기타 제품 유형 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
외용 크림
경피 패치
액체 현탁액
제7장 지역별·국가별 분석
세계의 프로테우스 증후군 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 프로테우스 증후군 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
프로테우스 증후군 시장 : 경쟁 구도
프로테우스 증후군 시장 : 기업 개요
Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
Merck Sharp & Dohme Corp Overview, Products and Services, Strategy and Financial Analysis
Intas Pharmaceuticals Ltd Overview, Products and Services, Strategy and Financial Analysis
Dr Reddy's Laboratories Ltd Overview, Products and Services, Strategy and Financial Analysis
Zydus Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Biocon Limited
Glenmark Pharmaceuticals Ltd
Curia Global
Concord Biotech Limited
Camber Pharmaceuticals
Chunghwa Chemical Synthesis & Biotech Co Ltd
Farmhispania Group SL
LGM Pharma LLC
ChemWerth Inc
Simson Pharma Limited
Actiza Pharmaceutical
AXXO GmbH
CFM Oskar Tropitzsch GmbH
MedicaPharma
Sumar Biotech LLP
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
프로테우스 증후군 시장 2029 : 새로운 기회를 제공하는 국가
프로테우스 증후군 시장 2029 : 새로운 기회를 제공하는 부문
프로테우스 증후군 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
ksm
영문 목차
영문목차
Proteus syndrome is a rare genetic disorder characterized by the abnormal and asymmetric overgrowth of bones, skin, and other tissues. It is caused by a mutation in the AKT1 gene, which triggers uncontrolled cell growth in specific areas of the body. This condition results in a highly variable appearance, with affected individuals displaying disproportionate tissue development. As a progressive disorder, Proteus syndrome worsens over time, often impacting the skeleton, skin, and connective tissues.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The primary product types used in the treatment of Proteus syndrome include tablets, capsules, injectables, and other forms. Tablets are a common oral medication form, offering precise dosages for effective treatment. These treatments are administered through oral, parenteral, or other delivery methods and are distributed through both online and offline channels to end users, including hospital pharmacies, retail pharmacies, and specialty clinics.
The proteus syndrome market research report is one of a series of new reports from The Business Research Company that provides proteus syndrome market statistics, including proteus syndrome industry global market size, regional shares, competitors with a proteus syndrome market share, detailed proteus syndrome market segments, market trends and opportunities, and any further data you may need to thrive in the proteus syndrome industry. The Proteus syndrome market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The proteus syndrome market size has grown strongly in recent years. It will grow from$1.30 billion in 2024 to $1.37 billion in 2025 at a compound annual growth rate (CAGR) of 5.2%. The growth during the historic period can be attributed to higher diagnosis rates, increased genetic research, greater adoption of precision medicine, expanded government initiatives, and a rise in the demand for genetic testing.
The proteus syndrome market size is expected to see strong growth in the next few years. It will grow to$1.66 billion in 2029 at a compound annual growth rate (CAGR) of 5.0%. The growth during the forecast period can be attributed to the increasing focus on personalized medicine, greater use of biomarkers, expanding telemedicine adoption, rising awareness of rare diseases, and the growing prevalence of Proteus syndrome. Key trends expected in the forecast period include technological advancements, innovations in gene therapy, AI-driven diagnostics, integration of big data analytics, and the development of personalized drugs.
The rising frequency of genetic mutations is expected to drive the growth of the Proteus syndrome market in the coming years. Genetic mutations are permanent alterations in DNA sequences that change genetic information, potentially leading to various diseases or unique traits. The increasing prevalence of genetic mutations is mainly due to environmental exposure to mutagens such as radiation, pollutants, and chemicals, which cause DNA damage and genetic changes. Proteus syndrome contributes to the understanding of genetic mutations by demonstrating how a somatic mutation in the AKT1 gene causes abnormal cell growth, offering valuable insights into mosaicism and disease progression. For example, in March 2022, the UK Health Security Agency reported 763 XE sequences and 637 cases in the UK, with XE mutations spreading and case numbers increasing across England. As such, the growing incidence of genetic mutations is fueling the expansion of the Proteus syndrome market.
The rise in research funding is expected to further accelerate the growth of the Proteus syndrome market. Research funding refers to financial support from governments, organizations, or institutions to facilitate scientific discovery, innovation, and technological progress. This increase in funding is primarily driven by the need to better understand the genetic causes of Proteus syndrome, improve diagnostic methods, and develop targeted treatments. The condition attracts significant research funding as it underscores the importance of advanced genetic and therapeutic studies, prompting investments from medical institutions, government bodies, and rare disease organizations. For instance, in August 2024, the BioIndustry Association, a UK-based trade association for life sciences and biotech, reported that the UK's life sciences and biotechnology sector secured $2.55 billion in investments during the first two quarters of the year, surpassing the $2.32 billion raised in 2023. Thus, the growing research funding is driving the development of the Proteus syndrome market.
Leading companies in the Proteus syndrome market are focusing on clinical trials to develop cutting-edge products such as PI3K-a inhibitors to improve treatment efficacy and expand therapeutic options. PI3K-a inhibitors are drugs that target the PI3K-alpha enzyme, which plays a crucial role in regulating cell growth and division. These inhibitors help manage Proteus syndrome by controlling abnormal tissue growth caused by mutations in the PIK3CA gene, which leads to excessive activation of the PI3K/AKT signaling pathway. For example, in November 2024, Risen (Suzhou) Pharma Technology Co., Ltd., a pharmaceutical company based in China, announced that its joint venture had received implicit approval for two clinical trials of its Class 1 new drug, RP903 tablets, under the acceptance numbers CXHL2400566 and CXHL2400565. RP903 is a PI3K-a inhibitor designed to target PIK3CA gene mutations associated with Proteus syndrome (PROS). This achievement underscores the company's commitment to advancing innovative treatments for rare diseases and enhancing the therapeutic options available for PROS patients.
Major players in the proteus syndrome market are Pfizer Inc., Merck Sharp & Dohme Corp, Intas Pharmaceuticals Ltd, Dr Reddy's Laboratories Ltd, Zydus Pharmaceuticals Inc., Biocon Limited, Glenmark Pharmaceuticals Ltd, Curia Global, Concord Biotech Limited, Camber Pharmaceuticals, Chunghwa Chemical Synthesis & Biotech Co Ltd, Farmhispania Group SL, LGM Pharma LLC, ChemWerth Inc, Simson Pharma Limited, Actiza Pharmaceutical, AXXO GmbH, CFM Oskar Tropitzsch GmbH, MedicaPharma, Sumar Biotech LLP, and Kachhela Medex Private Limited.
North America was the largest region in the proteus syndrome market in 2024 and it is expected to be the fastest-growing region in the forecast period. The regions covered in proteus syndrome report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the proteus syndrome market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The proteus syndrome market consists of revenues earned by entities providing services such as diagnostic testing, genetic counseling, specialized treatments, and patient care for managing the condition. The market value includes the value of related goods sold by the service provider or included within the service offering. The proteus syndrome market also includes sales of targeted therapies, pharmaceuticals, medical devices, and diagnostic tools. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Proteus Syndrome Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on proteus syndrome market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for proteus syndrome ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The proteus syndrome market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product Type: Tablets; Capsules; Injectables; Other Product Types
2) By Route of Administration: Oral; Parenteral; Other Route Of Administration
3) By Distribution Channel: Online; Offline
4) By End User: Hospital Pharmacy; Retail Pharmacy; Specialty Clinics
Subsegments:
1) By Tablets: Immediate-Release Tablets; Extended-Release Tablets; Effervescent Tablets
2) By Capsules: Hard Gelatin Capsules; Soft Gelatin Capsules; Delayed-Release Capsules
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Proteus Syndrome Market Characteristics
3. Proteus Syndrome Market Trends And Strategies
4. Proteus Syndrome Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Proteus Syndrome Growth Analysis And Strategic Analysis Framework
5.1. Global Proteus Syndrome PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Proteus Syndrome Market Growth Rate Analysis
5.4. Global Proteus Syndrome Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Proteus Syndrome Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Proteus Syndrome Total Addressable Market (TAM)
6. Proteus Syndrome Market Segmentation
6.1. Global Proteus Syndrome Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tablets
Capsules
Injectables
Other Product Types
6.2. Global Proteus Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Parenteral
Other Route Of Administration
6.3. Global Proteus Syndrome Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Online
Offline
6.4. Global Proteus Syndrome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacy
Retail Pharmacy
Specialty Clinics
6.5. Global Proteus Syndrome Market, Sub-Segmentation Of Tablets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Immediate-Release Tablets
Extended-Release Tablets
Effervescent Tablets
6.6. Global Proteus Syndrome Market, Sub-Segmentation Of Capsules, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hard Gelatin Capsules
Soft Gelatin Capsules
Delayed-Release Capsules
6.7. Global Proteus Syndrome Market, Sub-Segmentation Of Injectables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Intravenous (IV) Injectables
Intramuscular (IM) Injectables
Subcutaneous (SC) Injectables
6.8. Global Proteus Syndrome Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Topical Creams
Transdermal Patches
Liquid Suspensions
7. Proteus Syndrome Market Regional And Country Analysis
7.1. Global Proteus Syndrome Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Proteus Syndrome Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
